Novartis drug Tasigna received approval from the European Commission
Novartis received approval from the European Commission for Tasigna® (nilotinib) as a treatment for adult...
Arena and Eisai Complete End-of-Review Meeting with FDA
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with...
Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis
H. Lundbeck A/S announced that it has signed agreements with Zenobia Therapeutics (Zenobia) and Vernalis...
Merck Serono and San Raffaele Institute to Collaborate on Research
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced a strategic collaboration with the...
Addex Awarded EuropaBio’s Most Innovative SME Award
Allosteric modulation company Addex Pharmaceuticals announced that the company has been awarded EuropaBio’s Most Innovative...
Fluxion Biosciences Announces Product Launch of BioFlux 1000Z
Fuxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will...
GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals
GlaxoSmithKline plc announced that it has entered into an agreement to acquire Nanjing MeiRui Pharma...
Elan Drug Technologies Announces Completion of Enrolment in Phase 3
Elan Drug Technologies, a business unit of Elan Corporation, plc announced that Zogenix Inc, its...
Aurobindo Pharma receives FDA tentative approval for Duloxetine Hydrochloride Delayed Release Capsules
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from...
Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
Amgen announced that it will present data from several key Nplate(R) (romiplostim) studies at the...
